Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Elizabeth Gil Ramirez"'
Autor:
Candis Morrison, Elizabeth Gil Ramirez, Dickran Kazandjian, Elizabeth M. Hill, Monica Epstein, Michael Emanuel, Emily Bryer, Alexander Dew, Jennifer Jones, Kevin Camphausen, Ashley Carpenter
Publikováno v:
Blood. 136:10-11
Background: Multiple myeloma (MM) is the 2nd most common hematologic malignancy and remains incurable despite significant treatment advances over the last decade. Patients with relapsed/refractory multiple myeloma (RRMM), who have exhausted available
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7578a80b4baa66aca0b3d09278ded349
https://doi.org/10.1182/blood-2020-136176
https://doi.org/10.1182/blood-2020-136176
Autor:
Jeremy L. Davis, Bradford J. Wood, Elizabeth Gil Ramirez, Gagandeep Brar, Cecilia Monge Bonilla, Freddy E. Escorcia, Melissa Walker, Jennifer Jones, Tim F. Greten, Donna Mabry-Hrones, Austin G. Duffy, Deborah Citrin, David E. Kleiner, Seth M. Steinberg, Billel Gasmi, Jonathan M. Hernandez, Suzanne Fioravanti, Changqing Xie, Bernadette Redd
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 26(10)
Purpose: The effectiveness of immune checkpoint inhibitors (ICI) is limited in pancreatic ductal adenocarcinoma (PDAC). We conducted a phase I study to evaluate the safety of ICI with stereotactic body radiation therapy (SBRT) in patients with metast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4e6456ae1a28e453383372345b34396
https://pubmed.ncbi.nlm.nih.gov/33397682
https://pubmed.ncbi.nlm.nih.gov/33397682
Autor:
Raul C. Braylan, Dickran Kazandjian, Baris Turkbey, Esther Mena, Irina Maric, Liza Lindenberg, Seth M. Steinberg, Michael Emanuel, Candis Morrison, Maryalice Stetler-Stevenson, Constance M. Yuan, Kevin Camphausen, Joseph Roswarski, Jennifer Jones, Katherine R. Calvo, Elizabeth M. Hill, Alina Dulau-Florea, Hao-Wei Wang, Alexander Dew, Peter L. Choyke, William D. Figg, Elizabeth Gil Ramirez
Publikováno v:
The Oncologist
Oncologist
Oncologist
Lessons Learned Despite the initial optimism for using immune checkpoint inhibition in the treatment of multiple myeloma, subsequent clinical studies have been disappointing. Preclinical studies have suggested that priming the immune system with vari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc9333fd98fa2c7b04f5fd87c7782a4a
https://doi.org/10.1002/onco.13712
https://doi.org/10.1002/onco.13712